Profiles of patients who are advised to use human insulin Review article

Main Article Content

Grzegorz Dzida
Piotr Gajda
Katarzyna Pasterczyk

Abstract

Intolerance of higher doses of oral antidiabetic drugs is a signal to include insulin therapy. According to PTD guidelines of 2018 and reimbursement criteria, patients with a slight elevation of HbA1c should receive NPH insulin therapy.

Article Details

How to Cite
Dzida , G., Gajda , P., & Pasterczyk, K. (2018). Profiles of patients who are advised to use human insulin. Medycyna Faktow (J EBM), 11(4(41), 307-309. https://doi.org/10.24292/01.MF.0418.8
Section
Articles

References

1. Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). DOI: 10.2337/dci18-0033.
2. 2018 Guidelines on the management of diabetic patients. A position of Diabetes Poland. Clin. Diabet. 2018; 7: 1. DOI: 10.5603/DK.2018.0001.